Payer Matrix

Payer Matrix provides cost-containment and patient advocacy services focused on specialty drugs. The company partners with employers, health plans, and third-party administrators to help patients access high-cost medications through alternative funding programs and manufacturer assistance initiatives. It claims substantial savings for clients while supporting members in navigating complex benefit structures. The company has received URAC accreditation in healthcare management.

There has been controversy regarding its business model—major pharmaceutical companies have alleged that Payer Matrix enrolls insured patients into charitable patient assistance programs intended for the uninsured or underinsured, leading to lawsuits from manufacturers like AbbVie.

As of early 2024, the company remains active with over 150 employees across multiple U.S. offices.

No clinical results or therapeutic pipeline exist as it does not develop drugs.